Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2029

Conditions

Epilepsy, Temporal Lobe

Interventions

DRUG

Ferumoxytol

Ferumoxytol will be injected to enhance MRI images

Trial Locations (1)

RECRUITING

Peter S. Allen MRI Unit, Edmonton

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Alberta

OTHER